Company: QXO-PB
Filing Date: 2025-05-22
Form Type: 424B5
Source: 0001104659-25-052056
Chunk: 75

Company: QXO, Inc.
Filing Date: 2025-05-22
Form: 424B5
Chunk 75
---
 ​ | ​ | ​             | ​ | 642,022 | ​ | ​ |
| Total adjusted weighted-average shares                      | ​ | ​ | ​                  | ​ | 664,448 | ​ | ​ | ​ | ​                 | ​ |    657,022 | ​ | ​ | ​ | ​            | ​ | 657,022 | ​ | ​ | ​ | ​             | ​ | 657,022 | ​ | ​ | ​ | ​                 | ​ |  642,022 | ​ | ​ | ​ | ​            | ​ | 642,022 | ​ | ​ | ​ | ​             | ​ | 642,022 | ​ | ​ |
| Diluted net income per share                                | ​ | ​ | ​                  | $ |    0.21 | ​ | ​ | ​ | ​                 | $ |      -3.21 | ​ | ​ | ​ | ​            | $ |    0.52 | ​ | ​ | ​ | ​             | $ |    0.42 | ​ | ​ | ​ | ​                 | $ |    -0.21 | ​ | ​ | ​ | ​            | $ |   -0.14 | ​ | ​ | ​ | ​             | $ |   -0.06 | ​ | ​ |
| Shares of common stock issued and outstanding at period end | ​ | ​ | ​                  | ​ | 664,448 | ​ | ​ | ​ | ​                 | ​ |    657,022 | ​ | ​ | ​ | ​            | ​ | 657,022 | ​ | ​ | ​ | ​             | ​ | 657,022 | ​ | ​ | ​ | ​                 | ​ |  642,022 | ​ | ​ | ​ | ​            | ​ | 642,022 | ​ | ​ | ​ | ​             | ​ | 642,022 | ​ | ​ |

7

TABLE OF CONTENTS

### USE OF PROCEEDS
Unless we specify another use in the applicable prospectus supplement, we will use the net proceeds from the sale of the securities offered by us for general corporate purposes, which may include, among other things, debt repayment, working capital and capital expenditures. We may also use such proceeds to fund acquisitions of businesses or product lines that complement our current or any acquired business. We may set forth additional information on the use of net proceeds from the sale of the securities we offer under this prospectus in a